StonvexLoading…
StonvexStonvexStonvexCore line items from ILMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2023 2023-01-01 |
|---|---|---|---|---|
Revenue | $4.34B | $4.37B | $4.50B | $4.58B |
Operating Income | $807.00M | $-833.00M | $-1.07B | $-4.18B |
Net Income | $850.00M | $-1.22B | $-1.16B | $-4.40B |
EPS (Diluted) | $5.45 | $-7.69 | $-7.34 | $-28.00 |
Total Assets | $6.64B | $6.30B | $10.11B | $12.25B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.42B | $1.13B | $1.05B | $2.01B |
Free Cash Flow OCF − CapEx | $931.00M | $709.00M | $283.00M | $106.00M |
Shares Outstanding | 153.00M | 159.00M | 159.00M | 158.00M |